Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Translational Oncology Research International.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Translational Oncology Research International
Collaborator:
Genentech
Information provided by:
Translational Oncology Research International
ClinicalTrials.gov Identifier:
NCT00203411
First received: September 13, 2005
Last updated: February 16, 2011
Last verified: February 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | February 2012 (Final data collection date for primary outcome measure) |